Administration of atropine in the setting of acute myocardial infarction: potentiation of the ischemic process?
Atropine has also been suggested to potentially worsen the ischemic situation in patients who are in the midst of acute coronary ischemia. We report the case of a female patient with ischemic chest pain and third degree atrioventricular block who developed acute myocardial infarction (AMI) immediately after atropine administration. The use of atropine in this instance remains a reasonable option and should be strongly considered-despite this apparent complication. Undoubtedly in some cases, acute ischemia is intensified by hypoperfusion attributable to vagally mediated bradyarrhythmia; atropine is the antidote for such situations. An awareness of this potential adverse reaction coupled with a prudent selection of candidates for atropine therapy will show the risk/benefit ratio in each individual patient and, therefore, guide the clinician.
Brady
W J
WJ
Department of Emergency Medicine, University of Virginia, Charlottesville, VA 22906-0114, USA. wb4z@hscmail.mcc.virginia.edu
Perron
A D
AD
D000208:Acute Disease; D001285:Atropine / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*; D017202:Myocardial Ischemia / Q000150:complications* / Q000188:drug therapy*; D010276:Parasympatholytics / Q000009:adverse effects*
D010276:Parasympatholytics; D001285:Atropine